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Introduction: Conyza bonariensis (L.) Cronquist is a herbaceous
plant of the underbrush group. It is distributed worldwide and is
used to treat a variety of skin conditions.
 Objective: Evaluate the in vitro inhibitory activity of the tincture
from C. bonariensis leaves against fungi and bacteria causing
superficial infections. 
Methods: The tincture was obtained by alcoholic maceration of
dry leaves of C. bonariensis. Minimum inhibitory concentration
(MIC) of the tincture was determined against 53 isolates from
patients with superficial lesions and 6 reference strains; 20
Malassezia (7 M. sympodialis, 7 M. furfur, 6 M. globosa), 16
Candida (8 C. albicans, 8 C. parapsilosis), 17 dermatophytes (6
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Trichophyton rubrum, 6 Trichophyton mentagrophytes, 5
Microsporum canis) and 6 Staphylococcus aureus. 
 Results: A notable reduction in the viability of most of the
microorganisms evaluated was obtained at low concentrations
(under 10 % v/v) of the C. bonariensis tincture.
 Conclusions: Results allow to conclude that the C. bonariensis
tincture displays antibacterial activity against Staphylococcus
aureus and antifungal activity against the main fungi causing
superficial infections, such as dermatophytes, Candida and
Malassezia. MIC variations were found between genera and
species, but not within each species. These results may help
experts find a scientific explanation for the empirical use of the C.
bonariensis extract to treat various skin infections and revalue
traditional ethnomedical knowledge.
Key words: Conyza bonariensis (L.) Cronquist, antifungal
activity, antibacterial activity, skin infections.
RESUMEN
Introducción: Conyza bonariensis (L.) Cronquist es una planta
herbácea de distribución mundial que forma parte del grupo de las
malezas y es utilizada para tratar diversas afecciones de la piel. 
 Objetivo: Evaluar la actividad inhibitoria in vitro de la tintura de
las hojas de C. bonariensis contra hongos y bacterias causantes
de infecciones superficiales. 
 Métodos: La tintura se obtuvo mediante maceración alcohólica
de las hojas secas de C. bonariensis. La concentración inhibitoria
mínima (MIC) de la tintura se determinó en 53 aislados de
pacientes con lesiones superficiales y en 6 cepas de referencia;
20 Malassezia (7 M. sympodialis, 7 M. furfur, 6 M. globosa), 16
Candida (8 C. albicans, 8 C. parapsilosis), 17 dermatofitos
(6Trichophyton rubrum, 6 Trichophyton mentagrophytes, 5
Microsporum canis) y 6 Staphylococcus aureus. 
Resultados: Se obtuvo una marcada reducción de la viabilidad de
la mayoría de los microorganismos evaluados con bajas
concentraciones (menores a 10 % v/v) de la tintura de C.
bonariensis. 
 Conclusiones: Los resultados permitieron concluir que la tintura
de C. bonariensis tiene actividad antibacteriana contra
Staphylococcus aureus y actividad antifúngica contra los
principales hongos que causan infecciones superficiales como
dermatofitos, Candida y Malassezia. Se observaron variaciones de
las MIC entre género y entre especies, pero no se observaron
variaciones de las MIC dentro de las especies. Estos resultados
contribuyen a dar una explicación científica del uso empírico del
extracto de C. bonariensis en el tratamiento de varias infecciones
cutáneas y a revalorizar el conocimiento etnomédico tradicional.
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Since the World Health Organization1 supported the introduction
of resources of traditional medicine in health systems everywhere,
the use of medicinal plants has shown a marked increase in the
world. This decision was reaffirmed in the Ottawa Charter for
Health Promotion.2 At present, the program "Traditional Medicine"
have a plan of health monitoring which purpose is to recover
natural medical practices.3 Moreover, application of scientific
methods in selection and study of plants to validate the
properties from which are traditionally known,4 is increasingly
important in the field of research.5 The WHO 2014-2023 strategy
on Traditional Medicine reevaluate the strategy 2002-2005,3 and
points the course of traditional and complementary medicine for
the next decade.
The use of specific plants to cure some skin infections has been
the traditional medicine of different ethnic groups. Through
ethnomedical information, is known that juice of crushed fresh
leaves of Conyza bonariensis (L.) Cronquist (C. bonariensis) is
used to treat various skin lesions in Manabi province (Ecuador).
Rural people use it to cure "manchas blancas" (white macules),
referring to pityriasis versicolor.6 C. bonariensis is a native Latin
American herbaceous plant member of the Asteraceae family,
spread all over the world forming part of weeds group. Commonly
it is known as "canilla de venado", "rama negra", "mata negra" or
"hierba carnicera" by indigenous peoples.7-10
The aim of this study was to evaluate the in vitro inhibitory
activity of the tincture of C. bonariensis leaves against fungi and




Leaves of C. bonariensis (L.) Cronquist (Asteraceae) were hand
harvested in the agricultural farm of the Escuela Superior
Politécnica del Litoral (ESPOL), Guayaquil, Ecuador. A voucher
(code CIBE002) was deposited in the Herbario Nacional de






Leaves were washed under running water for 10 minutes and
shade dried for 1 hour at room temperature. After, treated with
sodium hypochlorite solution 5 % for 3 minutes and washed 3
times with sterile distilled water, according to Bissegger and
Sieber, 1994. Next, leaves were dried in a hot air oven (Memmert
SFB-400) at 45 °C to constant weight. Once dry, the leaves were
ground in a manual grinder and sifted with a mesh of 2 mm in
diameter.
The tincture was obtained by maceration of C. bonariensis leaves
with ethanol 96° for 24 hours in a closed vessel, with periodic
stirring, in a final ratio of 1 herb part for 20 alcohol parts (0.05




A total of 53 isolates including yeast, dermatophytes and bacteria
obtained from patients with skin infections were studied: 20
Malassezia (7M. sympodialis, 7 M. furfur, 6 M. globosa), 16
Candida (8 C. albicans, 8 C. parapsilosis), 17 dermatophytes (6
Trichophyton rubrum, 6Trichophyton mentagrophytes, 5
Microsporum canis) and 6 Staphylococcus aureus. All isolates
were previously identified by molecular and conventional methods
and deposited at Mycology and Bacteriology Culture Collection of
Instituto de Medicina Regional (IMR), Universidad Nacional del
Nordeste, Resistencia, Argentina.
Malassezia isolates were obtained from pityriasis versicolor,
seborrheic dermatitis and atopic dermatitis lesions. Candida
isolates were obtained from cutaneous candidiasis,
mucocutaneous candidiasis and onychomycosis; dermatophytes
isolates were obtained from tinea capitis, tinea corporis, tinea
unguium, tinea pedis, tinea interdigitalis and tinea cruris lesions
and bacteria isolated from skin infections.
As reference strains were used M. furfur CBS 7019,M. sympodialis
CBS 7222, M. globosa CBS 7886, C. albicans ATCC 64548, C.
parapsilosis ATCC 22019 and Staphylococcus aureus ATCC 25923.
 
Inhibitory activity assay
The inhibitory activity of the tincture was evaluated using the
agar dilution technique by surface dissemination.12
The inoculum suspensions used were adjusted to a concentration
equivalent to a 0,5 McFarland standard for fungus and bacterial
concentration was adjusted to 4 × 106 colony forming units per
mL (CFU/mL). After the inhibition test, bacterial viability was




Petri dishes of 9 cm with culture medium containing dilutions from
20 % v/v of the tincture were used. Then, according to the
obtained growth, intermediate dilutions were performed.
Culture medium, temperature and time of incubation, varied
according to the microorganism studied:
Malassezia spp.: Dixon agar, incubation at 32 °C up to 5 days.
  
Candida spp.: Sabouraud agar, incubation at 37 °C up to 48
hours.
  
Dermatophytes: potato dextrose agar (PDA), incubation at 28
°C up to 10 days.
  
Staphylococcus aureus: trypticase soy agar (Mueller-Hinton),
incubation at 35 °C up to 48 hours.
 
Plates were inoculated with 0,5 mL of the inoculum suspensions
poured onto the agar surface (flooding) and the excess liquid was
immediately removed.
The minimum inhibitory concentration (MIC) was defined as the
lowest concentration of the tincture at which growth was not
observed and was expressed as % (v/v).
As growth control, each microorganism was tested: a) only with
the extraction solvent, to rule out any possible effect of the
solvent and b) without addition neither the tincture nor the
extraction solvent, as growth positive control.
 
RESULTS
Table shows MICs against the main fungi and bacteria causing
superficial infections.
 
Table. Minimum inhibitory concentration % (v / v) of C.
bonariensis tincture against microorganism species tested

































































































































































































































































dermatitis 6.5    
 
DISCUSSION
Ethnopharmacology is defined as an ensemble of knowledge and
belief about plants, parts thereof or products deriving from them.
It focuses on the scientific study of indigenous medicines in order
to contribute, in the long-run, to improved health care in the
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regions of study, as well as search for pharmacologically unique
principles from existing indigenous remedies.14-16
Medicinal plants can be used whole or parts of them (leaves,
roots, seeds, flowers), fresh or in different preparations as
aqueous extracts, tinctures, essential oils, resins, balsams.17 As
inhabitants of Manabi do, several studies conducted in different
parts of the world showed that leaves are used more than others
parts of a plant.18-21
Tinctures are solutions of alcoholic or hydroalcoholic extraction
obtained from parts of medicinal plants22,23 and it is preferred by
the people because they concern a more practical use and better
results.24
Table shows MICs obtained, proving the antibacterial and
antifungal activity of C. bonariensis tincture against the main
fungi and bacteria causing superficial infections. No MICs
variations were observed among isolates of the same species, but
MICs variations were observed mainly with the genus.
Controls carried out demonstrated that in no case the
microorganism growth was affected by solvent. All microorganisms
studied grew in the absence of tincture.
Dermatophytes are the most frequent agents of superficial
mycoses. Showing different activity against species of the same
group, in this study the lowest and the highest MIC were
obtained with dermatophytes fungi (M. canis and T.
mentagrophytes). Moreover, different activity was observed
against species of the same genus such us T. rubrum and T.
mentagrophytes.
Similar to that observed with dermatophytes, Candida species
showed highly variable results. C. albicans the most frequently
agent of superficial candidiasis showed lower susceptibility than
C. parapsilosis.
Malassezia yeast species are considered to be the etiological
agents of pityriasis versicolor and Malassezia folliculitis, and can
be related as an associated agent or a contributory factor in
other dermatological entities. Considering its recognized use in
traditional medicine in Ecuador for the cure of the "white stain"
(pityriasis versicolor), the tincture of C. bonariensis was highly
active against the three Malassezia species tested, showing a low
variation of MICs interspecies. M. sympodialis, M. globosa and M.
furfur are the most frequent species related to skin lesions as
pityriasis versicolor, seborrheic dermatitis and atopic
dermatitis.25-27
S. aureus was included in this study because is frequently
isolated from skin infections. Some studies showed that ethanolic
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extract of C. bonariensis is active against S. aureus and other
bacteria.17,28 In this work, C. bonariensis tincture leaves has
proved to have activity activity against S. aureus too.
Traditional "healers" mainly use water to extract the compounds
with antimicrobial activity; however, extracts obtained with
organic solvents have a more consistent antimicrobial activity
compared to aqueous extracts as they allow greater extraction of
active compounds.29
El Zalabani et al. evaluated the antimicrobial activity of
hydroalcoholic extract of C. bonariensis but only against C.
albicans.30 Others studies showed that methanol, hexane and
ethyl acetate extracts of the aerial parts of C. bonariensis did not
show any activity againstC. albicans and S. aureus.31,32
However, Shah et al. studied the methanolic extract of C.
bonariensis and observed its antifungal activity against C.
albicans.33 In this work, ethanol was an effective solvent for
extraction of bioactive compounds and the ethanolic extract
proved to be active against the most microorganisms tested. In
addition, we must consider that ethyl alcohol has low toxicity
unlike methyl alcohol which is very dangerous, it can lead to
blindness and in severe intoxication cases cause death.34,35
Nowadays, the phytomedicine and ethnopharmacological
knowledge are advancing in great strides. The application of the
scientific method allows corroborate the traditional use of plants
as medicines and find more properties to those already known
since many years. This particular case opens up the possibility to
demonstrate the in vivo effectiveness of C. bonariensis tincture
leaves as an antifungal and antibacterial suitable to treat
superficial infections, both for use in humans and veterinary
medicine. A natural product would help to resolve the problem of
adherence to current therapy associated with the use of
synthetic drugs, because of its high costs, sometimes with bad
results and collateral effects.
The results allowed concluding that C. bonariensis tincture has
antibacterial activity against Staphylococcus aureus and
antifungal activity against the main fungi causing superficial
infections, such as dermatophytes, Candida and Malassezia.
MICs variations were observed intergenus and interspecies, but
no MICs variations were observed among intraspecies isolates.
These results contribute to the scientific explanation of the
empirical use of C. bonariensis extract in treating several skin






The authors declare no conflict of interest.
 
REFERENCES
1. WHO. ALMA-ATA 1978: Atención primaria de Salud. 1978. p. 1-
91.
2. WHO. Ottawa Charter for Health Promotion; 1986.
3. WHO. WHO Traditional Medicine Strategy: 2014-2023. 2013.
4. WHO. WHO Traditional Medicine Strategy 2002-2005. 2002.
5. Vilches Juanes T, Martínez Marrero CL, Fernández García A.
Plantas medicinales con acción diurética en Cuba [Internet]. 2010
[cited 2015 Nov 25]. Available from:
http://www.ilustrados.com/tema/6079/Plantas-medicinales-
accion-diuretica-Cuba-Revision.html
6. Manzano Santana P, Miranda M, Gutiérrez Y, García G, Orellana
T, Orellana-Manzano A. Efecto antiinflamatorio y antimicótico del
extracto alcohólico y composición química del aceite de hojas de
Conyza bonariensis (L.) Cronquist (canilla de venado). Rev Cuba
Plantas Med. 2011;16(1):13-23.
7. Papa JC, Tuesca D, Nisensohn L. Control tardío de rama negra
(Conyza bonariensis) sobre individuos sobrevivientes a un
tratamiento previo con glifosato. Rev Soja para Mejor la Prod.
2010;45:81-4.
8. Zuloaga FO, Morrone O. Catálogo de las plantas vasculares de
la República Argentina II. Missouri Botanical Garden Press. Missouri
Botanical Garden Press; 1999. 1331 p.
9. Freire SE, Urtubey E, Sancho G, Bayón ND, Katinas L, Gutiérrez
DG, et al. Inventario de la biodiversidad vegetal de la provincia de
Misiones: Asteraceae. Darwiniana. 2006;44(2):375-452.
10. Espinar LA, Novara LJ. Flora del valle de Lerma: Asteraceae
Dumort. Tr. III. Astereae. Aportes Botánicos Salta - Ser Flora
Herb MCNS, Fac Ciencias Nat Univ Nac Salta. 2005;7(12):1-118.
11. Bissegger M, Sieber TN. Assemblages of Endophytic Fungi in
Coppice Shoots of Castanea sativa. Mycol Soc Am.
1994;86(5):648-55.
12. Grange JM, Davey RW. Antibacterial properties of propolis
(bee glue). J R Soc Med. 1990;83(3):159-60.
13. Páramo L, Lomonte B, Pizarro-Cerdá J, Bengoechea JA, Gorvel
JP, Moreno E. Bactericidal activity of Lys49 and Asp49 myotoxic
phospholipases A2 from Bothrops asper snake venom: Synthetic
Lys49 myotoxin II-(115-129)- peptide identifies its bactericidal
region. Eur J Biochem. 1998;253(2):452-61.
30/11/2018 Mussin
http://www.revplantasmedicinales.sld.cu/index.php/pla/rt/printerFriendly/560/284 11/12
14. Patwardhan B. Ethnopharmacology and drug discovery. J
Ethnopharmacol. 2005;100(1-2):50-2.
15. Gilani AH, Rahman AU. Trends in ethnopharmacology. J
Ethnopharmacol. 2005;100(1-2):43-9.
16. Stepp JR, Moerman DE. The importance of weeds in
ethnopharmacology. J Ethnopharmacol. 2001;75(1):19-23.
17. Thabit RAS, Cheng X-R, Tang X, Sun J, Shi Y-H, Le G-W.
Antioxidant and antibacterial activities of extracts from Conyza
bonariensis growing in Yemen. Pak J Pharm Sci. 2015;28(1):129-
34.
18. Togola A, Diallo D, Dembélé S, Barsett H, Paulsen BS.
Ethnopharmacological survey of different uses of seven medicinal
plants from Mali (West Africa) in the regions Doila, Kolokani and
Siby. J Ethnobiol Ethnomed. 2005;1(7):1-9.
19. Yineger H, Yewhalaw D. Traditional medicinal plant knowledge
and use by local healers in Sekoru District, Jimma Zone,
Southwestern Ethiopia. J Ethnobiol Ethnomed. 2007;3:24.
20. Maregesi SM, Ngassapa OD, Pieters L, Vlietinck AJ.
Ethnopharmacological survey of the Bunda district, Tanzania:
Plants used to treat infectious diseases. J Ethnopharmacol.
2007;113(3):457-70.
21. Bekalo TH, Woodmatas SD, Woldemariam ZA. An
ethnobotanical study of medicinal plants used by local people in
the lowlands of Konta Special Woreda, southern nations,
nationalities and peoples regional state, Ethiopia. J Ethnobiol
Ethnomed. 2009;5(26):1-15.
22. Administración Nacional de Medicamentos, Alimentos y
Tecnología Médica (ANMAT). Farmacopea Argentina Séptima
Edición: Volumen I. 2003.
23. Ministerio de Salud de la Nación. Farmacopea Argentina Sexta
Edición. 1978. Available from:
http://www.anmat.gov.ar/fna/resena.htm
24. Hurrell JA, Puentes JP. Medicinal and aromatic species of
Asteraceae commercialized in the conurbation Buenos Aires-La
Plata (Argentina). Ethnobiol Conserv. 2013;2(7):1-40.
25. Giusiano G, Sosa MDLA, Rojas F, Vanacore ST, Mangiaterra M.
Prevalence of Malassezia species in pityriasis versicolor lesions in
northeast Argentina. Rev Iberoam Micol. Elsevier; 2010;27(2):71-
4.
26. Sosa M de los A, Rojas F, Mangiaterra M, Giusiano G.
Prevalencia de especies de Malassezia asociadas a lesiones de
dermatitis seborreica en pacientes de Argentina. Rev Iberoam
Micol. Revista Iberoamericana de Micología; 2013;30(4):239-42.
30/11/2018 Mussin
http://www.revplantasmedicinales.sld.cu/index.php/pla/rt/printerFriendly/560/284 12/12
27. Nakabayashi A, Sei Y, Guillot J. Identification of Malassezia
species isolated from patients with seborrhoeic dermatitis, atopic
dermatitis, pityriasis versicolor and normal subjects. Med Mycol.
2000;38:337-41.
28. Yaseen M, Irshad N, Qayyum MI, Kamal Y. Evaluation of
antibacterial and cholinomimetic activities of different extracts of
Conyza bonariensis. Indian J Adv Plant Res. 2014;1(4):37-40.
29. Das K, Tiwari RKS, Shrivastava DK. Techniques for evaluation
of medicinal plant products as antimicrobial agents: current
methods and future trends. J Med Plants Res. 2010;4(2):104-11.
30. El Zalabani SM, Hetta MH, Ismail AS. Genetic Profiling,
Chemical Characterization and Biological Evaluation of Two
Conyza Species Growing in Egypt. J Appl Pharm Sci.
2012;2(11):54-61.
31. Lopez A, Hudson JB, Towers GHN. Antiviral and antimicrobial
activities of Colombian medicinal plants. J Ethnopharmacol.
2001;77:189-96.
32. Shinwari ZK, Malik S, Karim AM, Faisal R, Qaiser M. Biological
Activities of Commonly Used Medicinal Plants From Ghazi Brotha,
Attock District. Pakistan J Bot. 2015;47(1):113-20.
33. Shah NZ, Muhammad N, Azeem S, Khan AZ, Samie M, Khan H.
Antimicrobial and phytotoxic properties of Conyza bonariensis.
Pharm Pharmacol Res. 2013;1(1):8-11.
34. Dolara JE. Salud y trabajo: Toxicidad De Los Disolventes.
1983. p. 26-31.




Recibido: 10 de abril de 2016. 
 Aprobado: 26 de febrero de 2017.
 
 
Javier Esteban Mussin. Instituto de Medicina Regional, Universidad
Nacional del Nordeste, CONICET. Resistencia, Argentina.
 Correo electrónico: javiermussin@hotmail.com
